Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Beta This is a new resource - your feedback will help us improve it. Learn More.

Corporate Integrity Agreement with Vista Clinical Diagnostics, LLC; Access Dermpath, Inc.; and Advanced Clinical Laboratories, Inc.

 |   | 

DOCUMENTS

AGREEMENT PRESS RELEASE

Three Clermont Labs Agree To Pay $2.45 Million To Settle False Claims Act Liability For Manipulating Diagnosis Codes

Published by the United States Department of Justice | View article on www.justice.gov

Orlando, FL – United States Attorney Roger B. Handberg announces today that Vista Clinical Diagnostics, LLC; Access Dermpath, Inc.; and Advanced Clinical Laboratories, Inc. have agreed to pay the United States, the State of Florida, the State of North Carolina, and the Commonwealth of Virginia $2,450,000 to resolve allegations that they violated the False Claims Act by submitting claims to Medicare and Medicaid that contained manipulated diagnosis codes.

Related Corporate Integrity Agreement

ENFORCEMENT ACTIONS

AG Moody’s Medicaid Fraud Control Unit Secures Half A Million Dollars For Florida Medicaid Program

Penalty Amount: $0

Filed under: State Enforcement Agencies

TALLAHASSEE, Fla.—Attorney General Ashley Moody’s Medicaid Fraud Control Unit secured a payment of more than half a million dollars to Florida Medicaid from laboratory services providers. Attorney General Moody’s MFCU, along with the federal government, the state of North Carolina and the Commonwealth of Virginia, secured the recovery from Vista Clinical Diagnostics, LLC, Access Dermpath, Inc., and Advanced Clinical Laboratories, Inc.—companies alleged to have violated the Federal False Claims Act and the False Claims Acts of the respective states by submitting false or fraudulent claims for laboratory testing to Medicaid and Medicare.